Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

NCT04148937

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +52 more
Locations
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Washington University Medical School St Louis, Missouri, United States
View Trial Details
Completed

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

NCT03890731

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +26 more
Locations
  • Tampa General Medical Group Tampa, Florida, United States
  • Eberhard-Karls-Universität Tübingen Tübingen, Baden-Wurttemberg, Germany
  • Universitätsklinikum Köln Cologne, North Rhine-Westphalia, Germany
  • A.O.U. Careggi Florence, Tuscany, Italy
View Trial Details
Completed

Diagnostic Performance of the Vesical Imaging-Reporting and Data System (VI-RADS) in Detecting Muscle-invasive Bladder Tumour (MIBC) in Clinical Practice: Comparison With Transurethral Resection of Bladder Cancer (TURB) and Evaluation of Diagnostic Accuracy According to Tumour Location

NCT06337591

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • AOU Hospital Ancona, Italy
  • IRCCS INRCA Hospital Ancona, Italy
  • Carlo Urbani Hospital Iesi, Italy
View Trial Details
Completed

A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)

NCT02951767

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Arizona Oncology - HOPE Wilmot Tucson, Arizona, United States
  • UCLA Los Angeles, California, United States
View all 77 locations
View Trial Details
Completed

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

NCT03329950

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
Locations
  • HonorHealth Research Insititute Scottsdale, Arizona, United States
  • Northside Hospital, Inc. Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
View Trial Details

Related conditions